Tag: Triplet

By iwano@_84

MEDIOLA Examines Triplet Therapy in Ovarian Cancer

At the 2020 European Society for Medical Oncology (ESMO) virtual congress, researchers presented results for safety and efficacy of olaparib plus durvalumab with or without bevacizumab in women with recurrent platinum-sensitive relapsed ovarian cancer who don’t have a germline BRCA mutation.

In this exclusive MedPage Today video, study author Yvette Drew, MBBS, PhD, from Northern Center for Cancer Care in Newcastle upon Tyne, England, discusses the updated data.

Following is a transcript of her remarks:

So I had the privilege of presenting updated results from the MEDIOLA phase II trial of two new cohorts, where we’re investigating the safety and efficacy of olaparib plus durvalumab with or without bevacizumab in women with recurrent platinum-sensitive relapsed ovarian cancer who don’t have a germline BRCA mutation. We previously reported at ESMO [2019] results of the doublet cohort of olaparib and durvalumab in women with germline BRCA mutations. But this

Read More